Evidence map›Paper›PMID 30874997›Full record

ArticleThe AAPS journal2019

A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic Patients.

Carlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, An Vermeulen

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carlos Pérez-RuixoJanssen Research & Development, Clinical Pharmacology & Pharmacometrics, Beerse, Belgium. cperezru@ITS.JNJ.com.
Bart RemmerieJanssen Research & Development, Clinical Pharmacology & Pharmacometrics, Beerse, Belgium.
Juan José Peréz-RuixoJanssen Research & Development, Clinical Pharmacology & Pharmacometrics, Beerse, Belgium.
An VermeulenJanssen Research & Development, Quantitative Sciences Consulting, Beerse, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-adherence to antipsychotic medication is a primary factor in disease relapse in schizophrenic patients. We sought to evaluate if plasma concentrations of the antipsychotic risperidone can be used as a predictor of treatment adherence and to identify the optimal plasma concentration threshold to reliably distinguish between adherent and non-adherent patients. A population pharmacokinetic model was used to simulate plasma risperidone steady-state trough concentrations in 1000 virtual patients, where 60% of the patients were 100% adherent to their medication, while 40% of the patients were non-adherent to their medication. The probability of adherence was assessed by receiver operating characteristic (ROC) analysis on C

Indexed as

Medication AdherenceAntipsychotic AgentsDrug MonitoringFalse Negative ReactionsFalse Positive ReactionsHumansModels, BiologicalPredictive Value of TestsRisperidoneROC CurveSchizophreniaAntipsychotic AgentsRisperidonediagnostic testdrug adherencedrug plasma concentrationspopulation PK model–based simulationROC analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.